XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 574,188 $ 620,129
Accounts receivable, net 116,545 114,042
Prepaid expenses and other current assets 7,011 8,689
Restricted cash 1,250 1,250
Convertible note hedges   1,115
Total current assets 698,994 745,225
Restricted cash, net of current portion 485 485
Accounts receivable, net of current portion 14,439 23,998
Property and equipment, net 6,660 7,575
Operating lease right-of-use assets 14,365 15,350
Deferred tax assets 304,538 333,294
Other assets 863 1,000
Total assets 1,040,344 1,126,927
Current liabilities:    
Accounts payable 795 935
Accrued research and development costs 5,673 15,896
Accrued expenses and other current liabilities 17,598 23,566
Current portion of operating lease liabilities 3,050 3,127
Current portion of convertible senior notes   116,858
Note hedge warrants 1 1,316
Total current liabilities 27,117 161,698
Convertible senior notes, net of current portion 395,850 337,333
Operating lease obligations, net of current portion 17,087 18,484
Other liabilities 9,227 3,501
Commitments and contingencies
Stockholders' equity:    
Class A Common Stock, $0.001 par value, 500,000,000 shares authorized and 153,319,417 shares issued and outstanding at September 30, 2022 and 500,000,000 shares authorized and 162,036,461 shares issued and outstanding at December 31, 2021 153 162
Additional paid-in capital 1,336,153 1,543,357
Accumulated deficit (745,243) (937,608)
Total stockholders' equity 591,063 605,911
Total liabilities and stockholders' equity $ 1,040,344 $ 1,126,927